Nitrofurantoin Pharmevid (Nitrofurantoin)

Nitrofurantoin is converted by bacterial nitroreductases into reactive intermediates that damage bacterial DNA and other macromolecules. This oxidative injury disrupts essential cellular processes, leading to bacterial cell death and eradication of the infection.

The dosage regimen for Nitrofurantoin Pharmevid is determined by the prescribing clinician based on the patient’s condition, renal function, and local treatment guidelines. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies but limited human data. It may be used during pregnancy only when clearly needed. Small amounts can be excreted in breast milk, so a risk‑benefit assessment is recommended for nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

The most common alternative for uncomplicated urinary tract infections is trimethoprim‑sulfamethoxazole (TMP‑SMX). Nitrofurantoin has a narrower spectrum focused on urinary pathogens and is less likely to promote resistance in gut flora, but it requires adequate renal function for urinary concentration, whereas TMP‑SMX can be used in a broader range of renal function.

Nitrofurantoin Pharmevid should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, direct sunlight, and excessive heat to maintain potency throughout the shelf life.

The medication is supplied as oral tablets that should be swallowed whole with a full glass of water. It may be taken with or without food, but taking it with food can reduce gastrointestinal discomfort in some patients.

Serious adverse events include pulmonary toxicity (interstitial lung disease), hepatic injury (elevated liver enzymes or jaundice), severe allergic reactions such as anaphylaxis, and hemolytic anemia in patients with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency. Prompt medical attention is required if any of these symptoms develop.

Nitrofurantoin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min), known hypersensitivity to nitrofurantoin or other nitrofurans, and individuals with G6PD deficiency due to risk of hemolysis. Caution is also advised for pregnant women, breastfeeding mothers, and patients with a history of pulmonary or hepatic disease.